The United Kingdom represents a unique proposition in clinical research, with a thriving and innovative private sector working hand in hand with the world's most comprehensive nationalised healthcare system.

​

At the forefront of the COVID-19 research response, the UK punches well above its population weight in terms of trials initiated and patients recruited across both industry and institutionally sponsored clinical trials. 

​

Benefiting from a world-leading academic sector, the UK births multiple small biotech trial sponsors every year to sit alongside several of the world's largest pharmaceutical companies. 

​

COG UK brings together senior decision-makers from across the spectrum of UK trial sponsors to hear from thought leaders within industry, regulator and academia alongside a group of the most trusted and innovative solution providers serving the UK market for two days of leading multi-stream agenda content and networking engagement at a luxury London hotel. 

​

We're delighted to host COG UK as the premier meeting place for the UK clinical trial sector and look forward to welcoming you in London in February.